Login / Signup

Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.

Jesse ElliottSasha van KatwykBláthnaid McCoyTammy CliffordBeth K PotterBecky SkidmoreGeorge A WellsDoug Coyle
Published in: PharmacoEconomics (2020)
CRD42018099591.
Keyphrases
  • drug resistant
  • multidrug resistant
  • acinetobacter baumannii
  • decision making
  • pseudomonas aeruginosa
  • childhood cancer